Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Julien Zuber

Showing results (41-50 of 112) with videos related to

Pageof 12
Sort By:
Transplantation|August 30, 2008
Determination of lowest possible creatinine in living-donor kidney renal transplant recipients based on donor kidney functionRebecca Sberro, Julien Zuber, Marc Froissart, et al.
European Journal of Ophthalmology|September 16, 2022
CMV-related anterior and intermediate uveitis in a kidney transplant recipient treated with belataceptAntoine Morel, Amina Chahrazed Debieb, David Mrejen, et al.
American Journal of Obstetrics and Gynecology|May 30, 2026
Anti-HLA Antibodies and Risk of Fetal Growth RestrictionPierre Hannoun, Marie Verdoux, Isabelle Jollet, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|February 29, 2024
Hot Spot of Complement Factor I Rare Variant p.Ile357Met in Patients With Hemolytic Uremic SyndromeNora Schwotzer, Fadi Fakhouri, Paula Vieira Martins, et al.
Kidney International Reports|December 22, 2025
Immunosuppression-Free Kidney Transplantation after Haploidentical Hematopoietic Stem Cell Transplantation in Fanconi AnemiaJessica Kachmar, Martin Castelle, David Saint Gilles, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|April 25, 2007
Long-term outcome of third kidney transplantsAlexandre Loupy, Dany Anglicheau, Caroline Suberbielle, et al.
Biomedicines|November 25, 2023
A Validated LC-MS/MS Method for Performing Belatacept Drug Monitoring in Renal TransplantationStéphanie Chhun, Mathieu Trauchessec, Sophie Melicine, et al.
Transplantation|September 1, 2017
Midterm Outcomes of 12 Renal Transplant Recipients Treated With Eculizumab to Prevent Atypical Hemolytic Syndrome RecurrenceCharlène Levi, Véronique Frémeaux-Bacchi, Julien Zuber, et al.
Transplant International : Official Journal of the European Society for Organ Transplantation|December 20, 2018
No clinical benefit of rapid versus gradual tapering of immunosuppression to treat sustained BK virus viremia after kidney transplantation: a single-center experienceArnaud Devresse, Claire Tinel, Agathe Vermorel, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|September 5, 2009
FOXP3-enriched infiltrates associated with better outcome in renal allografts with inflamed fibrosisJulien Zuber, Albane Brodin-Sartorius, Naël Lapidus, et al.
Pageof 12

Showing results (41-50 of 112) with videos related to

Sort By:
Pageof 12
Transplantation|August 30, 2008
Determination of lowest possible creatinine in living-donor kidney renal transplant recipients based on donor kidney functionRebecca Sberro, Julien Zuber, Marc Froissart, et al.
European Journal of Ophthalmology|September 16, 2022
CMV-related anterior and intermediate uveitis in a kidney transplant recipient treated with belataceptAntoine Morel, Amina Chahrazed Debieb, David Mrejen, et al.
American Journal of Obstetrics and Gynecology|May 30, 2026
Anti-HLA Antibodies and Risk of Fetal Growth RestrictionPierre Hannoun, Marie Verdoux, Isabelle Jollet, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|February 29, 2024
Hot Spot of Complement Factor I Rare Variant p.Ile357Met in Patients With Hemolytic Uremic SyndromeNora Schwotzer, Fadi Fakhouri, Paula Vieira Martins, et al.
Kidney International Reports|December 22, 2025
Immunosuppression-Free Kidney Transplantation after Haploidentical Hematopoietic Stem Cell Transplantation in Fanconi AnemiaJessica Kachmar, Martin Castelle, David Saint Gilles, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|April 25, 2007
Long-term outcome of third kidney transplantsAlexandre Loupy, Dany Anglicheau, Caroline Suberbielle, et al.
Biomedicines|November 25, 2023
A Validated LC-MS/MS Method for Performing Belatacept Drug Monitoring in Renal TransplantationStéphanie Chhun, Mathieu Trauchessec, Sophie Melicine, et al.
Transplantation|September 1, 2017
Midterm Outcomes of 12 Renal Transplant Recipients Treated With Eculizumab to Prevent Atypical Hemolytic Syndrome RecurrenceCharlène Levi, Véronique Frémeaux-Bacchi, Julien Zuber, et al.
Transplant International : Official Journal of the European Society for Organ Transplantation|December 20, 2018
No clinical benefit of rapid versus gradual tapering of immunosuppression to treat sustained BK virus viremia after kidney transplantation: a single-center experienceArnaud Devresse, Claire Tinel, Agathe Vermorel, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|September 5, 2009
FOXP3-enriched infiltrates associated with better outcome in renal allografts with inflamed fibrosisJulien Zuber, Albane Brodin-Sartorius, Naël Lapidus, et al.
Pageof 12